Days Sales in Receivables: The average number of days it takes to collect outstanding receivable amounts from customers. Calculated as: Number of Days in Period / Receivable Turnover
Verrica Pharmaceuticals Inc. (VRCA) had Days Sales in Receivables of 95.39 for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$5.09M |
|
$-8.07M |
|
$1.40M |
|
$3.69M |
|
$12.28M |
|
$-7.19M |
|
$-0.88M |
|
$-8.07M |
|
$-8.07M |
|
$-8.07M |
|
$-8.07M |
|
$-8.07M |
|
$-8.07M |
|
$-7.19M |
|
$-7.00M |
|
10.65M |
|
10.65M |
|
$-0.67 |
|
$-0.67 |
|
| Balance Sheet Financials | |
$42.54M |
|
$0.21M |
|
$4.59M |
|
$47.13M |
|
$16.44M |
|
$0.64M |
|
$5.95M |
|
$22.39M |
|
$24.74M |
|
$24.74M |
|
$24.74M |
|
17.18M |
|
| Cash Flow Statement Financials | |
$-17.63M |
|
-- |
|
$1.45M |
|
$46.33M |
|
$30.15M |
|
$-16.18M |
|
$3.32M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.59 |
|
-- |
|
-- |
|
0.03 |
|
0.04 |
|
72.49% |
|
-141.24% |
|
-141.24% |
|
-- |
|
-158.56% |
|
-158.56% |
|
$-17.63M |
|
-- |
|
-- |
|
-- |
|
0.11 |
|
0.63 |
|
0.94 |
|
|
Days Sales in Receivables |
95.39 |
-32.63% |
|
-32.63% |
|
-17.13% |
|
-31.80% |
|
$1.44 |
|
$-1.65 |
|
$-1.65 |
|